Maybe drug pricing isn’t so bipartisan after all

Since roughly Jan. 20, 2017, it’s been a truism that lowering the cost of prescription drugs was perhaps the only thing that united Republicans, Democrats, and President Trump. Yesterday’s House committee meeting on the topic suggests the story is a bit more complicated.

As STAT’s Nicholas Florko reports, a discussion of Rep. Nancy Pelosi’s plan to lower drug prices threw the Energy & Commerce Committee into partisan chaos, as Republicans accused Democrats of sabotaging bipartisan efforts to force through more strident reforms. There was also bickering and name-calling.

This is all happening the shadow of a looming impeachment inquiry, which, among many implications, could distract lawmakers and delay action on any new drug pricing legislation.

Read more.